Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 515
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07215065 | Examining Heavy Metal Exposure and Respiratory Health in Young Adult Electronic Cigarette Users | ||
| NCT06534424 | Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study | ||
| NCT06230159 | Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use | ||
| NCT02427451 | Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia | ||
| NCT01299714 | Community Awareness, Resources and Education (CARE II): Project 3 | ||
| NCT03258892 | Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy | ||
| NCT00852774 | Steep Trendelenburg Positioning on Intra-Ocular Pressure During Surgery for Endometrial Robotics Versus Laparotomy | ||
| NCT06089408 | Weighted Blanket Use to Reduce Anxiety in Oncology Patients | ||
| NCT07647068 | Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors | ||
| NCT03513562 | Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations | ||
| NCT01812005 | Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | ||
| NCT03578627 | Stress and Immunity Breast Cancer Project | ||
| NCT03333746 | Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT00201708 | Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer | ||
| NCT02722525 | Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer | ||
| NCT00201682 | Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma | ||
| NCT02512497 | Romidepsin Maintenance After Allogeneic Stem Cell Transplantation | ||
| NCT04439006 | Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization | ||
| NCT04733495 | Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment | ||
| NCT05304793 | Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer | ||
| NCT04972513 | Impact of E-cigarette Use on the Body | ||
| NCT04635683 | Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma | ||
| NCT03460483 | Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care | ||
| NCT06263153 | Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy | ||
| NCT01814501 | Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | ||
| NCT05342571 | A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer | ||
| NCT02837887 | Computerized Cognitive Behavior Therapy in Treating Depression in Patients With Cancer | ||
| NCT05418088 | Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies | ||
| NCT03199651 | Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT03892044 | Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma | ||
| NCT01129206 | Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy | ||
| NCT07150806 | RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma | ||
| NCT06930352 | Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy | ||
| NCT06396598 | Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer | ||
| NCT00754910 | Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease | ||
| NCT06757647 | Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | ||
| NCT01823549 | Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients | ||
| NCT06949943 | Pre-Operative Guided Meditation to Reduce Pre-Operative Anxiety in Patients Undergoing Cancer-Directed Surgery | ||
| NCT06950008 | A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer | ||
| NCT02788708 | Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer | ||
| NCT05453773 | Hookah Additive Research to Inform Product Standards | ||
| NCT05114005 | Tango for Neuropathy Among Breast Cancer Survivors | ||
| NCT05821088 | Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma | ||
| NCT01005758 | Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | ||
| NCT07455513 | A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer | ||
| NCT05336812 | Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia | ||
| NCT01988701 | Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease | ||
| NCT05158452 | Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer | ||
| NCT05325151 | Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer | ||
| NCT06222580 | SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation |
